Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia

Completed

Conditions: Schizophrenia

First Posted Date: 2005-11-02

Last Posted Date: 2013-07-03

Lead Sponsor: University of California, San Diego

Target Recruit Count: 2025

Registration Number: NCT00247637

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

and more 4 locations

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Phase 2

Completed

Conditions: HIV Infections

Interventions: Drug: Tenofovir
Drug: Abacavir

First Posted Date: 2005-09-22

Last Posted Date: 2021-09-24

Lead Sponsor: University of California, San Diego

Target Recruit Count: 21

Registration Number: NCT00214890

Locations: 🇺🇸
UCI, Irvine, California, United States
🇺🇸
USC, Los Angeles, California, United States
🇺🇸
University of California San Diego, San Diego, California, United States

and more 2 locations

African Descent and Glaucoma Evaluation Study

Conditions: Primary Open Angle Glaucoma

First Posted Date: 2005-09-22

Last Posted Date: 2021-07-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 1540

Registration Number: NCT00221923

Locations: 🇺🇸
University of Alabama-Callahan Eye Foundation, Prof. Bldg., Birmingham, Alabama, United States
🇺🇸
UCSD Hamilton Glaucoma Center, La Jolla, California, United States
🇺🇸
New York Eye & Ear Infirmary, New York, New York, United States

Diagnostic Innovations in Glaucoma Study

Conditions: Primary Open Angle Glaucoma
Myopia

First Posted Date: 2005-09-22

Last Posted Date: 2021-07-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 3000

Registration Number: NCT00221897

Locations: 🇺🇸
UCSD, Hamilton Glaucoma Center, La Jolla, California, United States

Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Phase 2

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: rituximab

First Posted Date: 2005-09-07

Last Posted Date: 2010-03-23

Lead Sponsor: University of California, San Diego

Target Recruit Count: 24

Registration Number: NCT00147966

Locations: 🇺🇸
UCSD CIT, La Jolla, California, United States

Women's Healthy Eating and Living Study

Completed

Conditions: Breast Cancer

Interventions: Behavioral: educational/counseling intervention
Behavioral: therapeutic dietary intervention

First Posted Date: 2004-06-03

Last Posted Date: 2019-06-10

Lead Sponsor: University of California, San Diego

Target Recruit Count: 3088

Registration Number: NCT00003787

Locations: 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸
University of California San Diego Cancer Center, La Jolla, California, United States
🇺🇸
Permanente Medical Group (060), Oakland, California, United States

and more 4 locations

Carotenoid Rich Diet in Treating Cervical Dysplasia

Phase 2

Withdrawn

Conditions: Cervical Cancer

First Posted Date: 2004-04-27

Last Posted Date: 2014-05-20

Lead Sponsor: University of California, San Diego

Registration Number: NCT00003094

Locations: 🇺🇸
University of California San Diego Cancer Center, La Jolla, California, United States

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Biological: anti-thymocyte globulin
Biological: filgrastim
Biological: graft-versus-tumor induction therapy
Biological: therapeutic allogeneic lymphocytes
Drug: cyclosporine
Drug: fludarabine phosphate
Drug: melphalan
Drug: methotrexate
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2003-12-11

Last Posted Date: 2023-06-05

Lead Sponsor: University of California, San Diego

Target Recruit Count: 5

Registration Number: NCT00074269

Locations: 🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

Rehabilitative Training for Older People With Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia

First Posted Date: 2003-10-30

Last Posted Date: 2013-06-14

Lead Sponsor: University of California, San Diego

Target Recruit Count: 240

Registration Number: NCT00071591

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States

Aortic Calcium: Epidemiology and Progression -- Ancillary to MESA

Completed

Conditions: Atherosclerosis
Coronary Arteriosclerosis
Cardiovascular Diseases
Heart Diseases

First Posted Date: 2003-04-18

Last Posted Date: 2013-07-12

Lead Sponsor: University of California, San Diego

Target Recruit Count: 1980

Registration Number: NCT00059124

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy